Association of cholecystectomy with metabolic syndrome in a Chinese population

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Shen, Chao ^a   Wu, Xiaoliang ^a   Xu, Chengfu ^a   Yu, Chaohui ^a   Chen, Peng ^a   Li, Youming ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CHINESE; CHOLECYSTECTOMY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GALLSTONE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PATIENT HISTORY OF SURGERY; RISK FACTOR; SURGICAL RISK; TREATMENT RESPONSE;

ADULT; AGED; CHINA; CHOLECYSTECTOMY; FEMALE; GALLSTONES; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; RISK FACTORS;

EID: 84895515044     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0088189     Document Type: Article

References (32)

1. Alberti KG, Zimmet P, Shaw J (2005) The metabolic syndrome-a new worldwide definition. Lancet 366: 1059-1062. (Pubitemid 41338752)
2. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, et al. (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112: 2735-2752. (Pubitemid 41532612)
3. Johnson WD, Kroon JJ, Greenway FL, Bouchard C, Ryan D, et al. (2009) Prevalence of risk factors for metabolic syndrome in adolescents: National Health and Nutrition Examination Survey (NHANES), 2001-2006. Arch Pediatr Adolesc Med 163: 371-377.
4. Beltran-Sanchez H, Harhay MO, Harhay MM, McElligott S (2013) Prevalence and trends of metabolic syndrome in the adult u.s. Population, 1999-2010. J Am Coll Cardiol 62: 697-703.
5. Ravikiran M, Bhansali A, Ravikumar P, Bhansali S, Dutta P, et al. (2010) Prevalence and risk factors of metabolic syndrome among Asian Indians: a community survey. Diabetes Res Clin Pract 89: 181-188.
6. Zuo H, Shi Z, Hu X, Wu M, Guo Z, et al. (2009) Prevalence of metabolic syndrome and factors associated with its components in Chinese adults. Metabolism 58: 1102-1108.
7. Sattar N, McConnachie A, Shaper AG, Blauw GJ, Buckley BM, et al. (2008) Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies. Lancet 371: 1927-1935.
8. Agrawal V, Shah A, Rice C, Franklin BA, McCullough PA (2009) Impact of treating the metabolic syndrome on chronic kidney disease. Nat Rev Nephrol 5: 520-528.
9. Hamaguchi M, Kojima T, Takeda N, Nakagawa T, Taniguchi H, et al. (2005) The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med 143: 722-728.
10. Despres JP, Lemieux I (2006) Abdominal obesity and metabolic syndrome. Nature 444: 881-887.
11. Petersen KF, Dufour S, Savage DB, Bilz S, Solomon G, et al. (2007) The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome. Proc Natl Acad Sci U S A 104: 12587-12594. (Pubitemid 47255198)
12. Mendez-Sanchez N, Chavez-Tapia NC, Motola-Kuba D, Sanchez-Lara K, Ponciano-Rodriguez G, et al. (2005) Metabolic syndrome as a risk factor for gallstone disease. World J Gastroenterol 11: 1653-1657. (Pubitemid 40520807)
13. Chen LY, Qiao QH, Zhang SC, Chen YH, Chao GQ, et al. (2012) Metabolic syndrome and gallstone disease. World J Gastroenterol 18: 4215-4220.
14. Ata N, Kucukazman M, Yavuz B, Bulus H, Dal K, et al. (2011) The metabolic syndrome is associated with complicated gallstone disease. Can J Gastroenterol 25: 274-276.
15. Kim SS, Lee JG, Kim DW, Kim BH, Jeon YK, et al. (2011) Insulin resistance as a risk factor for gallbladder stone formation in Korean postmenopausal women. Korean J Intern Med 26: 285-293.
16. Amigo L, Husche C, Zanlungo S, Lutjohann D, Arrese M, et al. (2011) Cholecystectomy increases hepatic triglyceride content and very-low-density lipoproteins production in mice. Liver Int 31: 52-64.
17. Juvonen T, Kervinen K, Kairaluoma MI, Kesaniemi YA (1995) Effect of cholecystectomy on plasma lipid and lipoprotein levels. Hepato-gastroenterology 42: 377-382.
18. Sonne DP, Hare KJ, Martens P, Rehfeld JF, Holst JJ, et al. (2013) Postprandial gut hormone responses and glucose metabolism in cholecystectomized patients. Am J Physiol Gastrointest Liver Physiol 304: G413-419.
19. Ali RB, Cahill RA, Watson RG (2004) Weight gain after laparoscopic cholecystectomy. Ir J Med Sci 173: 9-12. (Pubitemid 38811994)
20. Yazdankhah Kenary A, Yaghoobi Notash A Jr, Nazari M, Yaghoobi Notash A, Borjian A, et al. (2012) Measuring the rate of weight gain and the influential role of diet in patients undergoing elective laparoscopic cholecystectomy: a 6-month follow-up study. Int J Food Sci Nutr 63: 645-648.
21. Chavez-Tapia NC, Kinney-Novelo IM, Sifuentes-Renteria SE, Torres-Zavala M, Castro-Gastelum G, et al. (2012) Association between cholecystectomy for gallstone disease and risk factors for cardiovascular disease. Annals of hepatology 11: 85-89.
22. Ruhl CE, Everhart JE (2013) Relationship of non-alcoholic fatty liver disease with cholecystectomy in the US population. Am J Gastroenterol 108: 952-958.
23. Yu C, Xu C, Xu L, Yu J, Miao M, et al. (2012) Serum proteomic analysis revealed diagnostic value of hemoglobin for nonalcoholic fatty liver disease. J Hepatol 56: 241-247.
24. Xu C, Yu C, Ma H, Xu L, Miao M, et al. (2013) Prevalence and risk factors for the development of nonalcoholic Fatty liver disease in a nonobese chinese population: the zhejiang zhenhai study. Am J Gastroenterol 108: 1299-1304.
25. Alberti KG, Zimmet P, Shaw J (2006) Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 23: 469-480.
26. Chang Y, Sung E, Ryu S, Park YW, Jang YM, et al. (2008) Insulin resistance is associated with gallstones even in non-obese, non-diabetic Korean men. J Korean Med Sci 23: 644-650.
27. Malagelada JR, Go VL, Summerskill WH, Gamble WS (1973) Bile acid secretion and biliary bile acid composition altered by cholecystectomy. Am J Dig Dis 18: 455-459.
28. Pols TW, Noriega LG, Nomura M, Auwerx J, Schoonjans K (2011) The bile acid membrane receptor TGR5: a valuable metabolic target. Dig Dis 29: 37-44.
29. Trauner M, Claudel T, Fickert P, Moustafa T, Wagner M (2010) Bile acids as regulators of hepatic lipid and glucose metabolism. Dig Dis 28: 220-224.
30. Tanaka M, Ikeda S, Nakayama F (1984) Change in bile duct pressure responses after cholecystectomy: loss of gallbladder as a pressure reservoir. Gastroenterology 87: 1154-1159. (Pubitemid 14017086)
31. Lee YH, Pratley RE (2005) The evolving role of inflammation in obesity and the metabolic syndrome. Curr Diab Rep 5: 70-75.
32. Yudkin JS, Juhan-Vague I, Hawe E, Humphries SE, di Minno G, et al. (2004) Low-grade inflammation may play a role in the etiology of the metabolic syndrome in patients with coronary heart disease: the HIFMECH study. Metabolism 53: 852-857.